• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » U.S. Justice Dept. closes St. Jude Riata probe

U.S. Justice Dept. closes St. Jude Riata probe

May 8, 2013 By Arezu Sarvestani

St. Jude Medical's Riata leads

Healthcare giant St. Jude Medical (NYSE:STJ) revealed in a recent regulatory filing that U.S. Justice Dept. investigators closed a probe of the recalled Riata and Riata ST defibrillators leads.

The "civil investigative demand," initially launched in August 2012 by the Civil Division of the DoJ, seems to have closed without incident or allegations of misconduct related to the Riata leads.

"The CID appeared to relate to a review of whether circumstances surrounding the company’s Riata and Riata ST defibrillator lead products caused the submission of false claims to federal healthcare programs," according to a St. Jude regulatory filing. "The company provided the DoJ with material responsive to the CID in the fall 2012, and in March 2013, the DoJ informed the company that it had closed its investigation."

St. Jude’s Riata leads have been at the center of a high-profile recall that has drawn federal investigations, negative press and patient and shareholder lawsuits.

St. Jude pulled the devices off of shelves in 2010, citing issues with "externalized conductors as a result of inside-out abrasion." The FDA did not issue a recall notice on the device at the time, but has since given the measure Class I recall status, a category usually reserved for the highest-risk devices that pose a threat to patients.

Just last month the medical device maker was slapped with multiple lawsuits in California courts yesterday over the Riata defibrillator lead, alleging that the heart wires were defective and led to injuries or death for more than 30 patients.

St. Jude has been attempting to shield its newer Durata leads from the high-profile recall since the company was forced to concede that the Riata revision rates were higher than previously reported. The device maker has been busy ever since calming fears about the next-generation Durata leads.

Wall Street investors are keeping their eyes peeled for any sign of a problem with the Durata leads. In June 2012, a single report (later debunked) of a Durata lead failure similar to the kind that sank the Riata sent STJ shares plunging 6% in a single day.

Filed Under: Legal News, News Well, Recalls Tagged With: Cardiac Rhythm Management, stjudemedical, U.S. Justice Dept. (DOJ)

More recent news

  • Autonomix picks up key nerve ablation catheter patent
  • Affluent Medical can move to pivotal phase of artificial urinary sphincter study
  • Globus Medical announces $500M share repurchase program
  • Cook Medical warns of issue with angiographic catheter
  • Virtuoso Surgical reports first cases with robotic endoscopy system, plans FDA IDE submission

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy